ROBYN FOWLER: Open Payments
NPI 1679609358 · WOODSBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 43 payments from 12 companies in 2025. Trend: 2023 $629 · 2024 $1,026 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $290 |
| Novo Nordisk Inc | 8 | $257 |
| Exact Sciences Corporation | 2 | $124 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $91 |
| ABBVIE INC. | 5 | $88 |
| Indivior Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: Wegovy, BREZTRI, Auvelity, CAPLYTA, The Cologuard Plus Collection Kit, JARDIANCE, FARXIGA, AIRSUPRA.
Industry payments across MD — which companies pay providers there.
